Top Markets
Coin of the day
PLx Pharma Inc. PLx Pharma Inc.

PLx Pharma Inc.

PLXP
Hisse Senetlerindeki Sıralama #41011
PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery... PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery platform technology, having successfully transitioned into the commercial stage. The company's primary offerings include Vazalore 325 mg, which is formulated for individuals facing vascular incidents like heart attacks and clot-induced strokes, as well as for the management of pain and inflammation. Additionally, they provide Vazalore 81 mg in the form of liquid-filled aspirin capsules. Looking ahead, their product development pipeline features PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, both of which are in Phase I clinical trials for addressing pain, inflammation, and fever. PLx Pharma makes its products available to consumers through a variety of retail avenues, including pharmacies, major retailers, supermarkets, and online sales channels. Founded in 2002, PLx Pharma Inc. is headquartered in Sparta, New Jersey.
Hisse Fiyatı
$0.00575
Son senkronizasyon: 2023-05-23
Piyasa Değeri
$51.30K
Değişim (1 gün)
-17.86%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret PLx Pharma Inc. (PLXP)

Kategori

PLx Pharma Inc. (PLXP) için kazanç
2026 itibarıyla kazanç TTM: 0
PLx Pharma Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
PLx Pharma Inc. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç